This can lead to severe symptoms such as chronic nausea, vomiting, abdominal pain, and bloating
Similarly, without these outcomes, 40% plan to start and stop based on needs, compared to 22% with no side effects
The effect size was calculated here using the method of Cohens d for a t -test [49]
As a result, they do not benefit from the clinical use of PROMs and are underrepresented in clinical trials and PROM research, further exacerbating health inequalities
DM is one of the most common metabolic diseases worldwide, with around 530 million people currently affected and an estimated 1.3 billion diabetes patients in 2050
Patients should request a Certificate of Analysis for their specific medication batch